Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.
Taiwanese researchers are examining a new factor, R1R2, that may be able to stop fibrosis-promoting cells from migrating to the lungs. Their study, “R1R2 peptide ameliorates pulmonary fibrosis in ... Read more
Researchers have identified two types of lung cells, one with regenerative features and the other with scar-forming characteristics, according to a study published in the journal Cell. The research ... Read more
University of North Carolina Health Care researchers have made strides toward a stem cell treatment for lung diseases such as pulmonary fibrosis, COPD, and cystic fibrosis. In fact, they are ... Read more
Patients treated with Ofev (nintedanib) or Esbriet (pirfenidone) for pulmonary fibrosis in a real-world setting have similar rates of side effects as those reported in clinical trials testing the drugs, ... Read more
Patients with more severe idiopathic pulmonary fibrosis (IPF) also benefit from Esbriet (pirfenidone) treatment, as do IPF patients with moderate lung function impairment, according to two studies presented at ... Read more
How a natural compound — resveratrol, found in grapes and red wine — works to reduce the inflammation caused by a bacterial infection that is particularly worrisome in people with airway disorders, such as asthma ... Read more
ARIAD Pharmaceuticals announced that it has completed the New Drug Application for brigatinib it filed with the U.S. Food and Drug Administration (FDA), seeking market approval to use the treatment in patients with ... Read more